NCT06606600 · RECRUITING
Impacts of Kebbi Robot Intervention for Older Adults With Mild Dementia
This trial is testing whether sessions with a small social robot called Kebbi can improve thinking skills, heart rate patterns, and mood in older adults with mild dementia living in long-term care. Participants meet with the robot for 30 minutes, three times a week, for 12 weeks. It is a Phase NA trial, meaning it is more of a structured research study than a drug trial — exploring whether the approach works at all.
You may qualify if
- aged 65 years or over;
- mild dementia (MMSE score between (19-24) according to level of education;
- an ability to communicate in Mandarin or Taiwanese;
- has been admitted in dementia daycare centers at least 3 months.
You're excluded if
- have severe difficulty in communication;
- are totally dependent on carers for daily activity;
- have a diagnosed infectious disease, moderate or severe dementia, and severe mental illness such as schizophrenia and delusional disorder
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-05-28